Get the Stockscreener App
35.15
1.15%
0.40
After Hours:
35.31
0.16
+0.46%
Tempus Ai Inc stock is traded at $35.15, with a volume of 2.43M.
It is up +1.15% in the last 24 hours and down -9.76% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$34.75
Open:
$35.15
24h Volume:
2.43M
Relative Volume:
0.95
Market Cap:
$5.53B
Revenue:
$640.44M
Net Income/Loss:
$-743.28M
P/E Ratio:
-3.1137
EPS:
-11.2888
Net Cash Flow:
$-206.93M
1W Performance:
-6.32%
1M Performance:
-9.76%
6M Performance:
-11.79%
1Y Performance:
+0.00%
1-Day Range:
$34.35
$35.93
1-Week Range:
$31.36
$37.50
52-Week Range:
$22.89
$79.49
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
35.15 | 5.53B | 640.44M | -743.28M | -206.93M | -11.29 |
|
VEEV
Veeva Systems Inc
|
216.59 | 35.16B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
73.51 | 12.70B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
53.72 | 10.03B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
102.42 | 8.88B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.47 | 6.45B | 906.14M | -52.62M | 89.62M | -0.3621 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-09-24 | Initiated | Guggenheim | Buy |
| Nov-11-24 | Downgrade | Stifel | Buy → Hold |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
Tempus AI shares set to rally as Pelosi buys calls - Investing.com
Tempus AI, Inc. Majority Shareholder Sells $33M Worth of Stock - The Africa Logistics
Tempus AI, Inc : Good timing to go long again -January 20, 2025 at 11:06 am EST - Marketscreener.com
Tempus AI announces national launch of FDA-approved xT CDx test - MSN
TEM Insider Trade Alert! Majority Shareholder Sells $33M Worth of Tempus AI Stock - TipRanks
Avanza Fonder AB Purchases Shares of 35,414 Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Tempus AI's Bradley Keywell sells $33.1 million in stock - MSN
Tempus AI Stock Plunges 28.9% in Three Months: What's Next? - MSN
Tempus AI Inc (TEM): AI-Driven Healthcare Revolution - Insider Monkey
10 Must-Watch AI Stocks on Investors’ Radar - Insider Monkey
Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidia - Benzinga
Tempus AI, Inc. (NASDAQ:TEM) Major Shareholder Bradley A. Keywell Sells 265,000 Shares - MarketBeat
Insider Selling: Tempus AI, Inc. (NASDAQ:TEM) Major Shareholder Sells 170,720 Shares of Stock - MarketBeat
Tempus AI's Bradley Keywell sells $33.1 million in stock By Investing.com - Investing.com Australia
Tempus AI (NASDAQ:TEM) Shares Up 11.7%Should You Buy? - MarketBeat
30,486 Shares in Tempus AI, Inc. (NASDAQ:TEM) Acquired by Bouvel Investment Partners LLC - MarketBeat
Tempus AI, Inc. Announces the National Launch of FDA-Approved xT CDx Test -January 15, 2025 at 08:30 am EST - Marketscreener.com
Tempus AI, Inc. (NASDAQ:TEM) Short Interest Update - MarketBeat
Tempus AI Leads Wednesday’s Rally with FDA-Approved Diagnostic Device Launch – Market - HPBL
Why Tempus AI (TEM) Is Among Wednesday’s Top Gainers? - MSN
Tempus AI (NASDAQ:TEM) Stock Price Down 7.9%Should You Sell? - MarketBeat
Tempus AI (NASDAQ:TEM) Stock Price Up 11.7%Still a Buy? - MarketBeat
Tempus AI Shares Rise on Launch of Cancer-Profiling Device - MarketWatch
Tempus AI (NASDAQ:TEM) Shares Gap DownShould You Sell? - MarketBeat
Tempus Announces the National Launch of FDA-Approved xT CDx Test - Marketscreener.com
Tempus AI Launches FDA-Approved 648-Gene Cancer Diagnostic Test Nationwide - StockTitan
Tempus AI: Disappointing Q4 Preliminary Results, But Bullish Fundamental Update - Seeking Alpha
Tempus AI shares rated Buy by Loop Capital, target cut as Compass CRO softness weighs on guidance - Investing.com Canada
TEM Stock Declines Following Preliminary Q4 Sales Miss - MSN
Tempus announces preliminary fourth quarter revenue, shares fall - MSN
Tempus AI (TEM) Launches AI-Powered Whole-Genome Sequencing Test to Transform Precision Medicine - Insider Monkey
15 Important AI News and Ratings on Investors’ Radar - Insider Monkey
Loop Capital Has Lowered Expectations for Tempus AI (NASDAQ:TEM) Stock Price - MarketBeat
JPM25, Day 2: News from Nvidia, Tempus AI and Health Catalyst; A look at Children's Health Dallas' expansion plans - Fierce healthcare
Needham & Company LLC Reiterates "Buy" Rating for Tempus AI (NASDAQ:TEM) - MarketBeat
Tempus AI Revolutionizes Healthcare with Advanced Generative AI Platform Upgrade - StockTitan
Beyond The Numbers: 6 Analysts Discuss Tempus AI Stock - Benzinga
Lefkofsky, touting strong financials for Tempus, paints a rosy future for AI and medicine - Crain's Chicago Business
Cathie Wood's ARK Snaps Up Tempus AI Shares Despite Revenue Miss and Market Sell-Off - GuruFocus.com
Cathie Wood’s ARKG Loads Up on Tempus AI (NASDAQ:TEM) as Stock Plunges on Revenue Miss - TipRanks
Here’s Why Tempus AI, Inc (TEM) Is Among Monday’s Top Losers - MSN
Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025 - Benzinga
SB TEMPUS Signs Agreement with Konica Minolta To Acquire Shares of Konica Minolta REALM - Konica Minolta
10 Firms Drop on Bearish Statements, Disappointing Earnings - Insider Monkey
Tempus AI unveils whole-genome sequencing test for cancer By Investing.com - Investing.com Canada
Tempus AI Reports Preliminary 2024 Revenue of $693 Million, Shares Fall Over 14% - Yahoo Finance
Tempus AI reports 30% annual revenue growth in 2024 By Investing.com - Investing.com Australia
Tempus AI Shares Fall 11.7% After 4Q Revenue Projections Fall Below Expectations - MarketWatch
Tempus AI reports 30% annual revenue growth in 2024 - Investing.com
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):